SUCAMPO PHARMACEUTICALS INC's ticker is SCMP and the CUSIP is 864909106. A total of 181 filers reported holding SUCAMPO PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $44,367,000 | +52.4% | 2,471,718 | +0.2% | 0.07% | +45.8% |
| Q3 2017 | $29,103,000 | +16.0% | 2,466,418 | +3.2% | 0.05% | +6.7% |
| Q2 2017 | $25,099,000 | -2.8% | 2,390,418 | +1.9% | 0.04% | -4.3% |
| Q1 2017 | $25,810,000 | -9.6% | 2,346,418 | +11.4% | 0.05% | -11.3% |
| Q4 2016 | $28,552,000 | +34.0% | 2,107,218 | +21.7% | 0.05% | +26.2% |
| Q3 2016 | $21,307,000 | +302.6% | 1,730,916 | +258.7% | 0.04% | +281.8% |
| Q2 2016 | $5,293,000 | +289.5% | 482,527 | +287.9% | 0.01% | +266.7% |
| Q1 2016 | $1,359,000 | – | 124,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 1,304,376 | $23,414,000 | 7.30% |
| Kassirer Asset Management Corp | 291,784 | $5,238,000 | 5.39% |
| First Trust Capital Management L.P. | 637,578 | $11,445,000 | 2.19% |
| NEXTHERA CAPITAL LP | 510,486 | $9,163,000 | 1.69% |
| HAVENS ADVISORS LLC | 100,000 | $1,795,000 | 1.35% |
| Piermont Capital Management Inc. | 172,980 | $3,105,000 | 1.02% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 674,446 | $12,106,000 | 0.97% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 1,495,600 | $26,845,000 | 0.96% |
| LONGFELLOW INVESTMENT MANAGEMENT CO LLC | 200,000 | $3,590,000 | 0.87% |
| BOOTHBAY FUND MANAGEMENT, LLC | 332,075 | $5,961,000 | 0.87% |